Last reviewed · How we verify

NCT05906641

Modulation of Secondary Bile Acids Through the Intestinal Microbiota After Consumption of a High-protein Diet.

Completed NA Last updated 5 March 2024
What this trial tests

NA trial testing High-protein diet in Healthy in 22 participants. Completed in 30 December 2023.

Timeline
1 August 2023
Primary endpoint
30 November 2023
30 December 2023

Quick facts

Lead sponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment22
Start date1 August 2023
Primary completion30 November 2023
Estimated completion30 December 2023
Sites1 location across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — full company profile →

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate whether changes in the gut microbiota generated after the consumption of a high protein diet in healthy subjects, modify the production of secondary bile acids. In addition, it will be seen whether a high protein intake modifies postprandial glucose response and its relationship with gut microbiota composition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High-protein diet

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05906641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing